Jan 12, 2023 / 04:15PM GMT
Alexander Kramer -
Hello, everyone, and welcome to the Thursday morning session of the 41st Annual JPMorgan Healthcare Conference. My name is Alex Kramer and I'm an associate in the healthcare investment banking group here at JPMorgan. It is my pleasure to introduce our next presenting company, TELA Bio. I'll now turn it over to our presenter, CEO, Tony Koblish.
Antony Koblish - TELA Bio, Inc. - Co-founder, President, CEO & Director
Thank you, Alex. Thank you to JPMorgan as well for the invitation and the opportunity, and thank you for everybody listening both present and out there. First, I'll acknowledge a forward-looking statement. And next, we'll get into the company. So TELA Bio is a soft tissue company that's focused on the preservation and restoration of tissues in the operating room in the surgical suite. We work with general surgeons, plastic reconstructive surgeons, colorectal surgeons and trauma surgeons. We have an advanced portfolio of tissue reinforced matrices.
We're the only company on the market that has intellectual property and the
TELA Bio Inc at JPMorgan Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers